Vibration of effects resulting from network geometry in mixed-treatment comparisons: a case study on network meta-analyses of antidepressants in major depressive disorder.
VINATIER, C.; Palpacuer, C.; Scanff, A.; Naudet, F.
Show abstract
ObjectiveIt is frequent to find overlapping network meta-analyses (NMAs) on the same topic with differences in terms of both treatments included and effect estimates. We aimed to evaluate the impact on effect estimates of selecting different treatment combinations (i.e. network geometries) for inclusion in NMAs. DesignMultiverse analysis, covering all possible NMAs on different combinations of treatments. SettingData from a previously published NMA exploring the comparative effectiveness of 22 treatments (21 antidepressants and a placebo) for the treatment of acute major depressive disorder. ParticipantsCipriani et al (2018) explored a dataset of 116 477 patients included in 522 randomized controlled trials. Main outcome measuresFor each possible network geometry, we performed a NMA to estimate comparative effectiveness on treatment response and treatment discontinuation for the treatments included (231 between-treatment comparisons). The distribution of effect estimates of between-treatment comparisons across NMAs was computed, and the direction, magnitude, and statistical significance of the 1st and 99th percentiles were compared. Results4 116 254 different NMAs concerned treatment response. Among possible network geometries, 172/ 231 (74%) pairwise comparisons exhibited opposite effects between the 1st and 99th percentiles, 57/231 (25%) comparisons exhibited statistically significant results in opposite directions, 118 of 231 (51%) comparisons derived non-robust results in terms of statistical significance at 5% risk and 56/231 (24%) treatment pairs obtained robust results across meta-analyses. Comparisons based on indirect evidence only were associated with greater variability in effect estimates. Comparisons with small absolute values observed in the complete NMA more frequently obtained statistically significant results in opposite directions. Similar results were observed for treatment discontinuation. ConclusionIn this case study we observed that the selection of treatments to be included in a NMA could have considerable consequences on treatment effect estimations. Registrationhttps://osf.io/mb5dy
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- On the treatment effect heterogeneity of antidepressants in major depression. A Bayesian meta-analysis 94%
- Analysis of clinical trial registry entry histories using the novel R package cthist 92%
- Using numerical modelling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample 92%
Similar papers in this journal
- The use of the Registered Reports format for publication of randomized clinical trials: a cross-sectional study 93%
- Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed 93%
- High-cited favorable studies for COVID-19 treatments ineffective in large trials 93%
Similar papers in this journal
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 93%
- ZIBGLMM: Zero-Inflated Bivariate Generalized Linear Mixed Model for Meta-Analysis with Double-Zero-Event Studies 93%
- Synthesizing evidence from the earliest studies to support decision-making: to what extent could the evidence be reliable? 93%
Similar papers in this journal
- Tool to assess risk of bias due to missing evidence in network meta-analysis (ROB-MEN): elaboration and examples 94%
- Transparency and reporting characteristics of COVID-19 randomized controlled trials 93%
- Efficacy and safety of esketamine for treatment resistant depression: registered report for a Systematic Review with an Individual Patient Data Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials 92%
Similar papers in this journal
- Investigator-initiated versus industry-sponsored trials – Visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT) 93%
- Predictive approaches to heterogeneous treatment effects: a systematic review 92%
- Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.